Mustafa, F.; Chopra, H.; Baig, A.A.; Avula, S.K.; Kumari, S.; Mohanta, T.K.; Saravanan, M.; Mishra, A.K.; Sharma, N.; Mohanta, Y.K.
Edible Mushrooms as Novel Myco-Therapeutics: Effects on Lipid Level, Obesity and BMI. J. Fungi 2022, 8, 211.
https://doi.org/10.3390/jof8020211
AMA Style
Mustafa F, Chopra H, Baig AA, Avula SK, Kumari S, Mohanta TK, Saravanan M, Mishra AK, Sharma N, Mohanta YK.
Edible Mushrooms as Novel Myco-Therapeutics: Effects on Lipid Level, Obesity and BMI. Journal of Fungi. 2022; 8(2):211.
https://doi.org/10.3390/jof8020211
Chicago/Turabian Style
Mustafa, Faheem, Hitesh Chopra, Atif Amin Baig, Satya Kumar Avula, Sony Kumari, Tapan Kumar Mohanta, Muthupandian Saravanan, Awdhesh Kumar Mishra, Nanaocha Sharma, and Yugal Kishore Mohanta.
2022. "Edible Mushrooms as Novel Myco-Therapeutics: Effects on Lipid Level, Obesity and BMI" Journal of Fungi 8, no. 2: 211.
https://doi.org/10.3390/jof8020211
APA Style
Mustafa, F., Chopra, H., Baig, A. A., Avula, S. K., Kumari, S., Mohanta, T. K., Saravanan, M., Mishra, A. K., Sharma, N., & Mohanta, Y. K.
(2022). Edible Mushrooms as Novel Myco-Therapeutics: Effects on Lipid Level, Obesity and BMI. Journal of Fungi, 8(2), 211.
https://doi.org/10.3390/jof8020211